光啟科學(00439.HK)出售視頻分析軟件公司權益 涉代價1,180萬美元
光啟科學(00439.HK)公布,計劃出售目標公司AGENT VIDEO INTELLIGENCE 約16.5%股權,代價為1,180萬美元,部分以現金代價約139萬美元及部分以買方Irisity AB向公司發行及配發價值約1,041萬美元之買方股份之方式支付。
目標公司提供對監控視頻進行分析的視頻分析軟件,可供應用於保安、安全、交通及商業智能等領域。交易完成後,公司將不再持有目標公司任何權益。
公司預期,交易之所得款項淨額1,061萬美元(相當於約8,245萬港元)將用於投入新技術、產品研發以及補充營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.